ASCIA News
-
Updated ASCIA article on oral immunotherapy (OIT) for food allergy
24 May 2019: ASCIA has updated its information on oral immunotherapy (OIT) for food allergy to include information from a meta-analysis (a method to combine data from multiple studies) of 12 OIT trials. This meta-analysis was published in the Lancet journal in April 2019 and... -
ASCIA patient education resources reborn
22 May 2019: The team at ASCIA are very pleased to announce that stage three of the ASCIA Education Project is now complete. More than sixty ASCIA website articles for patients, consumers and carers underwent a comprehensive review over the past few months. The review focuse... -
Recent tick allergy publication supports ASCIA recommendations
7 May 2019: A study titled “Tick killing in situ before removal to prevent allergic and anaphylactic reactions in humans: a cross-sectional study” has recently been published. It is available open access from the Asia Pacific Allergy journal https://apallergy.org/DOIx.php?id... -
UK inquest into fatal anaphylaxis
6 May 2019: It is with great sadness that we read about the recent UK inquest into a case of fatal anaphylaxis of a 13 year old school student, Karanbir Cheema, who had multiple food allergies. https://apple.news/AH7nE6Jr3RHGTrMlPZVp7qQ The Coroner's Court heard that whilst... -
Novalac Allergy infant formula supply update
30 April 2019: Bayer Australia Ltd (Bayer) has advised ASCIA that Novalac Allergy formula is currently out of stock and ongoing stock shortages will continue over the coming months. Please note that other Novalac products are unsuitable for infants diagnosed with cow’s milk... -
National Allergy Strategy funding and World Allergy Week 2019
5 April 2019: ASCIA greatly appreciates the funding that has been provided by the Australian Government to implement National Allergy Strategy projects. This includes funding that was announced by the Health Minister today, Friday 5 April 2019, which will allow the continuat... -
International Women's Day
8 March 2019: Today, ASCIA is proud to have our three past Presidents and the current President Elect, working together at the inaugural National Immunodeficiency Strategy meeting. Prof Connie Katelaris, Prof Jo Douglass, Dr Melanie Wong and Prof Michaela Lucas have all made... -
Catalyst allergy program
13 February 2019: If you missed watching the Catalyst allergy program on ABC TV last night (12 February 2019), you can watch it on ABC iview https://iview.abc.net.au/show/catalyst Several ASCIA members were involved in the program, including Prof Connie Katelaris, Prof Diann...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information.Verify here.